BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10071215)

  • 1. Growth retardation and neonatal lethality in mice with a homozygous deletion in the C-terminal domain of RNA polymerase II.
    Litingtung Y; Lawler AM; Sebald SM; Lee E; Gearhart JD; Westphal H; Corden JL
    Mol Gen Genet; 1999 Feb; 261(1):100-5. PubMed ID: 10071215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the mammalian RNA polymerase II C-terminal domain (CTD) nonconsensus repeats in CTD stability and cell proliferation.
    Chapman RD; Conrad M; Eick D
    Mol Cell Biol; 2005 Sep; 25(17):7665-74. PubMed ID: 16107713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-Terminal Domain of RNA Polymerase II Is a Multivalent Targeting Sequence that Supports Drosophila Development with Only Consensus Heptads.
    Lu F; Portz B; Gilmour DS
    Mol Cell; 2019 Mar; 73(6):1232-1242.e4. PubMed ID: 30765194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations.
    West ML; Corden JL
    Genetics; 1995 Aug; 140(4):1223-33. PubMed ID: 7498765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation.
    Xiao H; Lis JT; Xiao H; Greenblatt J; Friesen JD
    Nucleic Acids Res; 1994 Jun; 22(11):1966-73. PubMed ID: 8029001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1.
    Peterson CL; Kruger W; Herskowitz I
    Cell; 1991 Mar; 64(6):1135-43. PubMed ID: 2004420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
    Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
    Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evolution of the RNA polymerase II CTD.
    Chapman RD; Heidemann M; Hintermair C; Eick D
    Trends Genet; 2008 Jun; 24(6):289-96. PubMed ID: 18472177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of the repetitive carboxyl-terminal domain of the largest subunit of mouse RNA polymerase II.
    Bartolomei MS; Halden NF; Cullen CR; Corden JL
    Mol Cell Biol; 1988 Jan; 8(1):330-9. PubMed ID: 3275873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removing quote marks from the RNA polymerase II CTD 'code'.
    Dieci G
    Biosystems; 2021 Sep; 207():104468. PubMed ID: 34216714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.
    Chapman RD; Palancade B; Lang A; Bensaude O; Eick D
    Nucleic Acids Res; 2004; 32(1):35-44. PubMed ID: 14704341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression analysis reveals a functional difference between the serines in positions two and five in the consensus sequence of the C-terminal domain of yeast RNA polymerase II.
    Yuryev A; Corden JL
    Genetics; 1996 Jun; 143(2):661-71. PubMed ID: 8725217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.
    Rosonina E; Blencowe BJ
    RNA; 2004 Apr; 10(4):581-9. PubMed ID: 15037767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from initiation to promoter proximal pausing requires the CTD of RNA polymerase II.
    Lux C; Albiez H; Chapman RD; Heidinger M; Meininghaus M; Brack-Werner R; Lang A; Ziegler M; Cremer T; Eick D
    Nucleic Acids Res; 2005; 33(16):5139-44. PubMed ID: 16157863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA polymerase II carboxy-terminal domain contributes to the response to multiple acidic activators in vitro.
    Liao SM; Taylor IC; Kingston RE; Young RA
    Genes Dev; 1991 Dec; 5(12B):2431-40. PubMed ID: 1752437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation of the RNA polymerase II C-terminal domain: circular dichroism of long and short fragments.
    Bienkiewicz EA; Moon Woody A; Woody RW
    J Mol Biol; 2000 Mar; 297(1):119-33. PubMed ID: 10704311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat-Specific Functions for the C-Terminal Domain of RNA Polymerase II in Budding Yeast.
    Babokhov M; Mosaheb MM; Baker RW; Fuchs SM
    G3 (Bethesda); 2018 May; 8(5):1593-1601. PubMed ID: 29523636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the minimal functional unit of the RNA polymerase II CTD from yeast to mammalian cells.
    Shah N; Decker TM; Eick D
    Biol Lett; 2019 May; 15(5):20190068. PubMed ID: 31088280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heptad-Specific Phosphorylation of RNA Polymerase II CTD.
    Schüller R; Forné I; Straub T; Schreieck A; Texier Y; Shah N; Decker TM; Cramer P; Imhof A; Eick D
    Mol Cell; 2016 Jan; 61(2):305-14. PubMed ID: 26799765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.